NP49119 Hepatitis C Medicines

A Modification Notice
by THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("NSS")

Source
Find a Tender
Type
Contract (Goods)
Duration
4 year
Value
£52M
Sector
HEALTH
Published
13 Apr 2023
Delivery
01 Jun 2019 to 31 Mar 2023
Deadline
n/a

Concepts

Location

All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014

Geochart for 1 buyers and 4 suppliers

1 buyer

3 suppliers

Description

Total Quantity or Scope

Lot 1 - This Framework Agreement is for the supply of medicines used in the treatment of Hepatitis C to NHS Scotland. This Lot is for the treatment cost per medicine. Lot 2 - This Framework Agreement is for the supply of medicines used in the treatment of Hepatitis C to NHS Scotland. This Lot is for the treatment spend cap.

Award Detail

1 Abbvie (Maidenhead)
  • NP49119 Hepatitis C Medicines
  • Reference: 010569-2023-np49119-1
  • Value: £51,787,422 [share]
  • Awarded to group of suppliers.
2 Merck Sharp & Dohme (Hoddesdon)
  • NP49119 Hepatitis C Medicines
  • Reference: 010569-2023-np49119-1
  • Value: £51,787,422 [share]
  • Awarded to group of suppliers.
3 Gilead Sciences (London)
  • NP49119 Hepatitis C Medicines
  • Reference: 010569-2023-np49119-1
  • Value: £51,787,422 [share]
  • Awarded to group of suppliers.
4 Abbvie (Maidenhead)
  • NP49119 Hepatitis C Medicines
  • Reference: 010569-2023-np49119-1
  • Value: £51,787,422 [share]
  • Awarded to group of suppliers.

CPV Codes

  • 33600000 - Pharmaceutical products

Indicators

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. ** The estimated value(s) of the Framework Agreement referred to in Section V.2.4 (comprising two (2) Lots) cover(s) the twenty two (22) month contract duration and the twenty four (24) month extension period of the Framework Agreement. (SC Ref:728894)

Reference

Domains